Literature DB >> 17562833

Limb-girdle muscular dystrophy in the Netherlands: gene defect identified in half the families.

A J van der Kooi1, W S Frankhuizen, P G Barth, C J Howeler, G W Padberg, F Spaans, A R Wintzen, J H J Wokke, G-J B van Ommen, M de Visser, E Bakker, H B Ginjaar.   

Abstract

Pheno- and genotype correlation is attempted in a Dutch cross-sectional study on limb- girdle muscular dystrophy. Sarcoglycans, caveolin-3, calpain-3, and dysferlin were analyzed on muscle tissue. Mutation analysis of the calpain-3, caveolin-3, and fukutin-related protein gene was executed in successive order for all samples. In 51% of all families a classifying diagnosis was made. Several new mutations in LGMD2A, B, and C patients have been found in this population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562833     DOI: 10.1212/01.wnl.0000264853.40735.3b

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  Recombinant MG53 protein modulates therapeutic cell membrane repair in treatment of muscular dystrophy.

Authors:  Noah Weisleder; Norio Takizawa; Peihui Lin; Xianhua Wang; Chunmei Cao; Yan Zhang; Tao Tan; Christopher Ferrante; Hua Zhu; Pin-Jung Chen; Rosalie Yan; Matthew Sterling; Xiaoli Zhao; Moonsun Hwang; Miyuki Takeshima; Chuanxi Cai; Heping Cheng; Hiroshi Takeshima; Rui-Ping Xiao; Jianjie Ma
Journal:  Sci Transl Med       Date:  2012-06-20       Impact factor: 17.956

Review 2.  Plasma Membrane Repair: A Central Process for Maintaining Cellular Homeostasis.

Authors:  Alisa D Blazek; Brian J Paleo; Noah Weisleder
Journal:  Physiology (Bethesda)       Date:  2015-11

3.  Left ventricular deformation abnormalities in a patient with calpainopathy-a case from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.

Authors:  Attila Nemes; Lívia Dézsi; Péter Domsik; Anita Kalapos; Tamás Forster; László Vécsei
Journal:  Quant Imaging Med Surg       Date:  2017-12

4.  Frequency of the FKRP mutation c.826C>A in isolated hyperCKemia and in limb girdle muscular dystrophy type 2 in German patients.

Authors:  Frank Hanisch; Dörte Grimm; Stephan Zierz; Marcus Deschauer
Journal:  J Neurol       Date:  2009-10-10       Impact factor: 4.849

5.  Phenotypic variability in siblings with calpainopathy (LGMD2A).

Authors:  J Schessl; M C Walter; G Schreiber; U Schara; C R Müller; H Lochmüller; C G Bönnemann; R Korinthenberg; J Kirschner
Journal:  Acta Myol       Date:  2008-10

6.  Clinical, Neurophysiological, Radiological, Pathological, and Genetic Features of Dysferlinopathy in Saudi Arabia.

Authors:  Norah Alharbi; Rawan Matar; Edward Cupler; Hindi Al-Hindi; Hatem Murad; Iftteah Alhomud; Dorota Monies; Ali Alshehri; Mossaed Alyahya; Brian Meyer; Saeed Bohlega
Journal:  Front Neurosci       Date:  2022-02-22       Impact factor: 4.677

7.  Muscular dystrophy with marked Dysferlin deficiency is consistently caused by primary dysferlin gene mutations.

Authors:  Mafalda Cacciottolo; Gelsomina Numitone; Stefania Aurino; Imma Rosaria Caserta; Marina Fanin; Luisa Politano; Carlo Minetti; Enzo Ricci; Giulio Piluso; Corrado Angelini; Vincenzo Nigro
Journal:  Eur J Hum Genet       Date:  2011-04-27       Impact factor: 4.246

8.  Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population.

Authors:  Fiona L M Norwood; Chris Harling; Patrick F Chinnery; Michelle Eagle; Kate Bushby; Volker Straub
Journal:  Brain       Date:  2009-09-18       Impact factor: 13.501

9.  How to tackle the diagnosis of limb-girdle muscular dystrophy 2A.

Authors:  Marina Fanin; Anna Chiara Nascimbeni; Elisabetta Tasca; Corrado Angelini
Journal:  Eur J Hum Genet       Date:  2008-10-15       Impact factor: 4.246

Review 10.  A Journey with LGMD: From Protein Abnormalities to Patient Impact.

Authors:  Dimitra G Georganopoulou; Vasilis G Moisiadis; Firhan A Malik; Ali Mohajer; Tanya M Dashevsky; Shirley T Wuu; Chih-Kao Hu
Journal:  Protein J       Date:  2021-06-10       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.